Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
3.12M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
41M
-
Shares change
-
-2.26M
-
Total reported value, excl. options
-
$261M
-
Value change
-
-$25.1M
-
Put/Call ratio
-
0.76
-
Number of buys
-
50
-
Number of sells
-
-39
-
Price
-
$6.35
Significant Holders of Passage BIO, Inc. - COMMON STOCK (PASG) as of Q4 2021
111 filings reported holding PASG - Passage BIO, Inc. - COMMON STOCK as of Q4 2021.
Passage BIO, Inc. - COMMON STOCK (PASG) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6.96M shares), FRAZIER MANAGEMENT LLC (5.01M shares), Versant Venture Management, LLC (4.96M shares), BlackRock Inc. (3.49M shares), Deep Track Capital, LP (3.22M shares), New Leaf Venture Partners, L.L.C. (2.5M shares), VANGUARD GROUP INC (1.92M shares), Woodline Partners LP (1.92M shares), FMR LLC (1.79M shares), and GREAT POINT PARTNERS LLC (1.52M shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.